ACORDA SHARES TRIPLE ON MS DRUG DATA

Shares of Acorda Therapeutics Inc. more than tripled Monday, hitting a new 52-week high, after the biotech drug developer announced the success of a late-stage clinical trial to test its treatment to improve the walking ability of multiple sclerosis patients.

Yahoo Finance (http://biz.yahoo.com/ap/060925/acorda_mover.html?.v=1)